Mostrando
1
al
20
de
50
resultados
Smart-4-Fabry: Smart multifunctional GLA-nanoformulation for Fabry disease
CENTRO DE INVESTIGACION BIOMEDICA EN RED CIBER
tramitó un
H2020:
Lysosomal storage disorders (LSD) diseases are a group of rare diseases that currently lack a definitive cure. LSD incidence is about 1:5,000 - 1:10,000, representing a serious global health problem....
2017-01-01 | Financiado
2017-01-01 | Financiado
B-CAST: Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes
STICHTING HET NEDERLANDS KANKER INSTITUUTANTONI VAN LEEUWENHOEK ZIEKENHUIS
tramitó un
H2020:
Breast tumours are heterogeneous, and result from the complex interplay of multiple lifestyle/environmental and genetic risk factors. Through the EU-funded COGS project, we have identified a large num...
2015-09-01 | Financiado
2015-09-01 | Financiado
PHYLOCANCER: Phylogeography and somatic evolution of cancer tumor cells
UNIVERSIDADE DE VIGO
tramitó un
FP7:
By far, most evolutionary research has focused on the changes that occur in the germline of individuals across generations, within and between species. For different reasons, much less attention has b...
2014-10-01 | Financiado
2014-10-01 | Financiado
4D-GENOME: Dynamics of human genome architecture in stable and transient gene expression changes
FUNDACIO PRIVADA CENTRE DE REGULACIO GENOMICA
tramitó un
FP7:
The classical view of genomes as linear sequences has been replaced by a vision of nuclear organization that is both dynamic and complex, with chromosomes and genes non-randomly positioned in the nucl...
2014-06-01 | Financiado
2014-06-01 | Financiado
BES-2014-070327: DETERMINACION ESTRUCTURAL DE GENOMAS Y DOMINIOS GENOMICOS
FUNDACIO PARC CIENTIFIC DE BARCELONA
tramitó un
AEI:
2014-01-01 | Financiado
SHOCKOMICS: MULTISCALE APPROACH TO THE IDENTIFICATION OF MOLECULAR BIOMARKERS IN ACUTE HEART FAILURE INDUCED BY SHOCK
POLITECNICO DI MILANO
tramitó un
FP7:
The management of cardiovascular stability in shock patients is of paramount importance in critical care. New, cutting edge knowledge is necessary to overcome the shortcomings of available therapies,...
2013-10-01 | Financiado
2013-10-01 | Financiado
HEALS: Health and Environment-wide Associations based on Large population Surveys
SORBONNE UNIVERSITE
tramitó un
FP7:
Assessing individual exposure to environmental stressors and predicting health outcomes implies that both environmental exposures and epi/genetic variations are reliably measured simultaneously. HEALS...
2013-10-01 | Financiado
2013-10-01 | Financiado
BBMRI-LPC: BBMRI - Large Prospective Cohorts
HELSINGIN YLIOPISTO
tramitó un
FP7:
In recent years, biomedical research has crossed international borders in large, collaborative studies showing the value of multidisciplinarity and scale advantage. This has yielded valuable insights...
2013-02-01 | Financiado
2013-02-01 | Financiado
IBD-CHARACTER: Inflammatory Bowel Disease CHARACTERization by a multi-modal integrated biomarker study
THE UNIVERSITY OF EDINBURGH
tramitó un
FP7:
We propose a collaborative effort to advance our understanding of the inflammatory bowel diseases Ulcerative Colitis and Crohns Disease and to increase diagnostic precision in detection of the disease...
2012-12-01 | Financiado
2012-12-01 | Financiado
RD-CONNECT: RD-CONNECT: An integrated platform connecting registries, biobanks and clinical bioinformatics for rare disease research
UNIVERSITY OF NEWCASTLE UPON TYNE
tramitó un
FP7:
Despite examples of excellent practice, rare disease (RD) research is still mainly fragmented by data and disease types. Individual efforts have little interoperability and almost no systematic connec...
2012-11-01 | Financiado
2012-11-01 | Financiado
BLUEPRINT: A BLUEPRINT of Haematopoietic Epigenomes
STICHTING RADBOUD UNIVERSITEIT
tramitó un
FP7:
In response to the call for a high impact initiative on the human epigenome, the BLUEPRINT Consortium has been formed with the aim of generating at least 100 reference epigenomes and studying them to...
2011-10-01 | Financiado
2011-10-01 | Financiado
ITFoM: IT Future of Medicine
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
tramitó un
FP7:
Data-rich, individualised medicine poses unprecedented challenges for IT, in hardware, storage and communication. We propose a data-driven, individualised medicine of the future, based on molecular/ph...
2011-05-01 | Financiado
2011-05-01 | Financiado
AirPROM: Airway Disease PRedicting Outcomes through Patient Specific Computational Modelling
UNIVERSITY OF LEICESTER
tramitó un
FP7:
The airways diseases asthma and chronic obstructive pulmonary disease affect over 400 million people world-wide and cause considerable morbidity and mortality. Airways disease costs the European Union...
2011-03-01 | Financiado
2011-03-01 | Financiado
ESGI: European Sequencing and Genotyping Infrastructure
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
tramitó un
FP7:
The objective of this project is the integration of world class high-throughput sequencing and genotyping facilities that will provide sequencing and genotyping technologies and data analysis methodol...
2011-02-01 | Financiado
2011-02-01 | Financiado
PTA2011-6755-I: Análisis y caracterización de comportamientos en modelos animales de experimentación
FUNDACIO PARC CIENTIFIC DE BARCELONA
tramitó un
AEI:
2011-01-01 | Financiado
SAF2011-30508-C02-01: ENTIDADES QUIMICAS MULTIFUNCIONALES: DISEÑO, SINTESIS Y APLICACIONES TERAPEUTICAS
FUNDACIO PARC CIENTIFIC DE BARCELONA
tramitó un
AEI:
LOS LIGANDOS MULTIFUNCIONALES PUEDEN LLEGAR AS SER UNAS HERRAMIENTAS QUIMICAS MUY VALIOSAS PARA EL DESARROLLO DE NUEVOS AGENTES TERAPEUTICOS, MAS POTENTES, SELECTIVOS Y CON EFECTOS SECUNDARIOS MINIMIZ...
2011-01-01 | Financiado
2011-01-01 | Financiado
SAF2011-30391: DETECCION DE VARIANTES GENETICAS Y ESTRUCTURALES DE MANERA ROBUSTA Y EFICIENTE A PARTIR DE DATOS DE SECUENCIACION A GRAN ESCALA
FUNDACIO PARC CIENTIFIC DE BARCELONA
tramitó un
AEI:
LA RAPIDA EVOLUCION DE LAS TECNOLOGIAS PARA LA SECUENCIACION DE GENOMAS LAS HA LLEVADO A SUSTITUIR AL GENOTIPADO EN EL ESTUDIO GENETICO DE ENFERMEDADES A PEQUEÑA ESCALA (P. EJ. ESTUDIO DE MUTACIONES...
2011-01-01 | Financiado
2011-01-01 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.
Tecnologías
#Sin Completar
Datos compañía
CNAE
72 - Investigación y desarrollo.
Empleados
177 Empleados.
Dirección
BARCELONA
(CATALUÑA)
.
NIF
G61482832
Objeto Social
N.D.